Genenta Science S.P.A. ADR (GNTA)
4.06 +0.11 (+2.78%) 09:30 ET [NASDAQ]
3.98 x 1 4.14 x 4
Realtime by (Cboe BZX)
3.98 x 1 4.14 x 4
Realtime - - (-) -
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select FieldsSymbol | GNTA | ANL | INO | ||
Company | Genenta Science S.P.A. ADR | Adlai Nortye Ltd American Depositary Shares | Inovio Pharma | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 4.06 | 1.9800 | 1.8700 | ||
High | 4.06 | 2.0000 | 1.9250 | ||
Low | 4.06 | 1.9700 | 1.8400 | ||
Last | 4.06 | 1.9700 | 1.9300 | ||
Change | +0.11 | -0.0100 | +0.0200 | ||
% Change | +2.78% | -0.51% | +1.05% | ||
Volume | 630 | 3,489 | 227,444 | ||
20-Day Average Volume | 7,471 | 29,554 | 563,185 | ||
Previous Close | 3.95 | 1.9800 | 1.9100 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 3.83 | 1.9726 | 1.7307 | ||
20-Day Raw Stochastic | 81.82% | 54.90% | 93.27% | ||
20-Day Relative Strength | 53.93% | 47.23% | 52.93% | ||
Weighted Alpha | -7.95 | -76.10 | -74.51 | ||
Today's Opinion | 64% Sell | 100% Sell | 64% Sell | ||
Previous Opinion | 64% Sell | 88% Sell | 64% Sell | ||
Last Month's Opinion | 40% Sell | 80% Sell | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +6.01% since 04/23/25 | -1.50% since 04/23/25 | +1.87% since 04/23/25 | ||
Low | 3.76 on 04/24/25 | 1.8300 on 04/25/25 | 1.8100 on 04/28/25 | ||
High | 4.22 on 04/24/25 | 2.2000 on 04/28/25 | 1.9400 on 04/29/25 | ||
1-Month | |||||
%Chg | +2.27% since 03/28/25 | +1.55% since 03/28/25 | +10.12% since 03/28/25 | ||
Low | 3.34 on 04/07/25 | 1.6900 on 04/17/25 | 1.4200 on 04/09/25 | ||
High | 4.22 on 04/24/25 | 2.2000 on 04/28/25 | 1.9400 on 04/29/25 | ||
3-Month | |||||
%Chg | +1.50% since 01/30/25 | -4.37% since 01/30/25 | -8.85% since 01/30/25 | ||
Low | 3.34 on 04/07/25 | 1.6900 on 04/17/25 | 1.4200 on 04/09/25 | ||
High | 4.83 on 03/05/25 | 2.7500 on 02/20/25 | 2.3300 on 02/21/25 | ||
6-Month | |||||
%Chg | -23.90% since 10/30/24 | -3.43% since 10/30/24 | -65.74% since 10/30/24 | ||
Low | 3.34 on 04/07/25 | 1.6900 on 04/17/25 | 1.4200 on 04/09/25 | ||
High | 5.89 on 11/29/24 | 3.8900 on 11/11/24 | 5.8000 on 11/06/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 72,246 | 73,062 | 70,045 | ||
Shares Outstanding, K | 18,290 | 36,900 | 36,673 | ||
Annual Sales | 0 | 5,000,000 | 220,000 | ||
Annual Net Income | -9,640,000 | -104,870,000 | -107,250,000 | ||
Last Quarter Sales | N/A | 0 | 120,000 | ||
Last Quarter Net Income | N/A | -63,397,000 | -19,380,000 | ||
60-Month Beta | 0.66 | -1.03 | 1.84 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | N/A on 09/29/23 | -0.69 on 03/18/25 | ||
Latest Earnings Date | 04/04/25 | 04/18/25 | 05/13/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |